Funding agencies: CNPq, CAPES, FAPEMIG and Asklepios-Med. NPR is a CNPq SWO scholarship recipient. IGB and ELMV are post-doctoral fellows of CAPES and CNPq, respectively. IBM holds a CNPq undergraduate grant. ALT and HJR are awarded a CNPq fellowship. AP is funded by Asklepios-Med.
Plasma levels of soluble tumor necrosis factor receptors are associated with cognitive performance in Parkinson's disease
Article first published online: 3 DEC 2013
© 2013 International Parkinson and Movement Disorder Society
Volume 29, Issue 4, pages 527–531, April 2014
How to Cite
Rocha, N. P., Teixeira, A. L., Scalzo, P. L., Barbosa, I. G., de Sousa, M. S., Morato, I. B., Vieira, É. L. M., Christo, P. P., Palotás, A. and Reis, H. J. (2014), Plasma levels of soluble tumor necrosis factor receptors are associated with cognitive performance in Parkinson's disease. Mov. Disord., 29: 527–531. doi: 10.1002/mds.25752
Relevant conflicts of interest/financial disclosures: Nothing to report.
Full financial disclosures and author roles may be found in the online version of this article.
- Issue published online: 3 APR 2014
- Article first published online: 3 DEC 2013
- Manuscript Accepted: 21 OCT 2013
- Manuscript Revised: 9 OCT 2013
- Manuscript Received: 10 JUN 2013
This article has been cited by:
- 1Biomarkers of cognitive decline in Parkinson's disease, Parkinsonism & Related Disorders, 2015, 21, 5, 431, ,
- 3Inflammatory markers are associated with general cognitive abilities in schizophrenia and bipolar disorder patients and healthy controls, Schizophrenia Research, 2015, 165, 2-3, 188, , , , , , , , , , , , ,
- 4Insights into Neuroinflammation in Parkinson’s Disease: From Biomarkers to Anti-Inflammatory Based Therapies, BioMed Research International, 2015, 2015, 1, , ,
- 5TNFR1 absence protects against memory deficit induced by sepsis possibly through over-expression of hippocampal BDNF, Metabolic Brain Disease, 2015, 30, 3, 669, , , , , ,